TITLE

CHINA RENEWS ROCKY MOUNTAIN'S LICENSE FOR 2001

PUB. DATE
February 2001
SOURCE
Worldwide Biotech;Feb2001, Vol. 13 Issue 2, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Deals with the business license given by the Fujian Provincial Hygiene Bureau to Rocky Mountain Ginseng Inc., a manufacturer and marketer of drugs in China.
ACCESSION #
4080715

 

Related Articles

  • From Europe to China--a new focus. Wechsler, Jill // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p20 

    Focuses on the pharmaceutical industry in the People's Republic of China. Signing of the Mutual Recognition Agreement on pharmaceutical plant inspection between the United States and Europe; Upgrading of domestic pharmaceutical capabilities in the country; Difficulty of drug distribution in the...

  • Homeopathic drugs naturally want spot in mainstream market. Magiera, Marcy; Colford, Steven W. // Advertising Age;8/31/92, Vol. 63 Issue 35, p3 

    Reports that marketers of homeopathic medicines want to write a prescription for the American mainstream and they are spending marketing dollars doing it. Remedies that treat an ailment with small doses of natural substances; Commonly available in Europe; Homeopathic marketers expect that to...

  • New drugs often not that new.  // Aging;1991, Issue 362, p44 

    Reports on a study by the Senate Special Committee on Aging that found the vast majority of new pharmaceuticals placed on the market have little or no advantage over the usually less expensive drug therapies.

  • Pharmaceutical companies.  // Business News New Jersey;1998 Book of Lists, Vol. 11, p100 

    Ranks pharmaceutical companies in New Jersey by number of employees in their payroll. Includes Johnson & Johnson; Merck & Co.; Bristol-Myers Squibb; Schering-Plough; Novartis Pharmaceuticals.

  • Merger of the medicines. Nadeau, Jean Benoit; Dionisi, Sandra // CA Magazine;Jan/Feb96, Vol. 129 Issue 1, p24 

    Discusses the impact of the changes in the health care system on the pharmaceutical industry in Canada. Increase in research and development spending; Formation of alliances or merger with other pharmaceutical or biotech companies as a means for pharmaceuticals to sustain their market share;...

  • The pharmacist is a health care expert.  // Current Health 1;May91, Vol. 14 Issue 9, p22 

    Describes the role of the pharmacist in health care. Retail pharmacists; Hospital pharmacists; Pharmacokinetics; Pharmaceutics.

  • Untitled.  // DCI;Nov93, Vol. 153 Issue 5, p8 

    Presents news items on the pharmaceutical industry. Restructuring of Japan's Kao Corp.; Death of Croda chemist Don Suddaby and W. Gwynne Thomas, former head of the Royal Pharmaceutical Society's Department of Pharmaceutical Sciences; Formation of a subsidiary of Takeda U.S.A., Inc. in Toronto,...

  • Drug makers score on defense.  // DCI;Apr94, Vol. 154 Issue 4, p6 

    Focuses on the tenacity of the pharmaceutical industry in defending its image using considerable advertising and promotion skills. Attacks on pricing policies; Tax exemptions for manufacturing in Puerto Rico.

  • Washington letter.  // DCI;Jan1995, Vol. 156 Issue 1, p8 

    Reports on lawsuits against brand name drug manufacturers filed by pharmacy groups seeking to end `discriminatory pricing.' Elaborate pricing mechanism set up to give discounts to institutions, hospitals and health management organizations for bulk buying; Charges of violation of Sherman...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics